Use of phosphotyrosine-containing peptides to target SH2 domains: Antagonist peptides of the Crk/CrkL-p130Cas axis
Methods in Enzymology · 2024 · 301-342
DOI: 10.1016/bs.mie.2024.04.013 ↗Kurz gefasst
Fachartikel in der Zeitschrift Methods in Enzymology, 2024. Verfasst von Justin T Douglas und 3 weiteren Autor:innen. Beteiligte Einrichtung: Nuclear Magnetic Resonance Core Lab, University of Kansas, Lawrence, KS, United States. Hauptthemen laut MEDLINE: Crk-Associated Substrate Protein, src Homology Domains, Proto-Oncogene Proteins c-crk, Phosphotyrosine. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 112 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS, NCRR NIH HHS, NIH HHS.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Nuclear Magnetic Resonance Core Lab, University of Kansas, Lawrence, KS, United States.
- Computational Chemical Biology Core, Molecular Graphics and Modeling Laboratory, University of Kansas, Lawrence, Kansas, United States.
- High Throughput Screening Laboratory, University of Kansas, Lawrence, KS, United States.
- Department of Pediatrics, Children's Mercy Kansas City and University of Missouri Kansas City School of Medicine, Kansas City, MO, United States.
Förderung
- NIGMS NIH HHS
- NCRR NIH HHS
- NIH HHS
- National Science Foundation
- Cancer Center, University of Kansas
- National Institutes of Health
- National Institute of General Medical Sciences
- Children's Mercy Hospital
Zitieren
APA
Douglas, J. T., Johnson, D. K., Roy, A., & Park, T. (2024). Use of phosphotyrosine-containing peptides to target SH2 domains: Antagonist peptides of the Crk/CrkL-p130Cas axis. Methods in Enzymology, 301-342. https://doi.org/10.1016/bs.mie.2024.04.013
Vancouver
Douglas JT, Johnson DK, Roy A, Park T. Use of phosphotyrosine-containing peptides to target SH2 domains: Antagonist peptides of the Crk/CrkL-p130Cas axis. Methods in Enzymology. 2024:301-342. doi:10.1016/bs.mie.2024.04.013
BibTeX
@article{Douglas2024,
author = {Douglas, Justin T and Johnson, David K and Roy, Anuradha and Park, Taeju},
title = {Use of phosphotyrosine-containing peptides to target SH2 domains: Antagonist peptides of the Crk/CrkL-p130Cas axis},
journal = {Methods in Enzymology},
year = {2024},
pages = {301--342},
doi = {10.1016/bs.mie.2024.04.013}
}
EUVIMED